EmploisEntreprisesGénérateur de CVConnexionPublier une offreTélécharger l'app
Pharmaflo

Pharmaflo

PharmaFlo’s mission is to produce the finest, most reliable plant-based products for pharmaceutical clients worldwide. Our state-of-the-art facility is designed to harvest high-quality and high concentrations of particular molecules and secondary metabolites from plants. In all we do, respect for the environment is our primary concern. We’re proud to say that in the industry of indoor growing facilities, our revolutionary design combined with Quebec’s lowered electrical usage and alternative recuperation systems make our facility one of the most energy efficient worldwide, all crops included. Our outputs versus consumed energy ratios are among the most efficient on the planet. Our facility is furnished by the best equipment suppliers to achieve a state-of-the-art AI-operated system with high density vertical farming. Our partnerships facilitate improved accessibility for the standardization of carefully selected strains for their ability to deliver high concentrations of in-demand molecules. We continue to devote our research to the development of patented in vitro strains.

À propos de Pharmaflo

PharmaFlo’s mission is to produce the finest, most reliable plant-based products for pharmaceutical clients worldwide. Our state-of-the-art facility is designed to harvest high-quality and high concentrations of particular molecules and secondary metabolites from plants. In all we do, respect for the environment is our primary concern. We’re proud to say that in the industry of indoor growing facilities, our revolutionary design combined with Quebec’s lowered electrical usage and alternative recuperation systems make our facility one of the most energy efficient worldwide, all crops included. Our outputs versus consumed energy ratios are among the most efficient on the planet. Our facility is furnished by the best equipment suppliers to achieve a state-of-the-art AI-operated system with high density vertical farming. Our partnerships facilitate improved accessibility for the standardization of carefully selected strains for their ability to deliver high concentrations of in-demand molecules. We continue to devote our research to the development of patented in vitro strains.